Cargando…

Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations

PURPOSE: The carbohydrate-binding protein Galectin-3 is increased in several inflammatory diseases and has recently been forwarded as a systemic biomarker in chronic obstructive pulmonary disease (COPD). In this longitudinal study, we characterized the level of systemic Galectin-3 using blood from s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundqvist, Martina, Andelid, Kristina, Ekberg-Jansson, Ann, Bylund, Johan, Karlsson-Bengtsson, Anna, Lindén, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903965/ https://www.ncbi.nlm.nih.gov/pubmed/33642857 http://dx.doi.org/10.2147/COPD.S283372

Ejemplares similares

Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease
por: Andelid, Kristina, et al.
Publicado: (2015)

Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
por: Andelid, Kristina, et al.
Publicado: (2015)

Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis
por: Andelid, Kristina, et al.
Publicado: (2021)

Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)
por: Casara, Alvise, et al.
Publicado: (2022)

Novel inhibitory effect of galectin-3 on the respiratory burst induced by Staphylococcus aureus in human neutrophils
por: Venkatakrishnan, Vignesh, et al.
Publicado: (2023)

Association of Serum Galectin-3 with the Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Feng, Wei, et al.
Publicado: (2017)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
por: Ball, Peter
Publicado: (1995)

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values
por: Dal Negro, Roberto W, et al.
Publicado: (2014)

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units
por: Sundh, Josefin, et al.
Publicado: (2015)

Comparison of clinical characteristics between chronic bronchitis and non-chronic bronchitis in patients with chronic obstructive pulmonary disease
por: Choi, Joon Young, et al.
Publicado: (2022)

The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review
por: Wu, Jian-jun, et al.
Publicado: (2020)

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
por: Jivcu, Cristian, et al.
Publicado: (2009)

A study of infective and other factors in exacerbations of chronic bronchitis
por: McHardy, Valentine U., et al.
Publicado: (1980)

Infection in acute exacerbations of chronic bronchitis: a clinical perspective
por: Read, R.C.
Publicado: (1999)

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease
por: Lee, Jin Hwa, et al.
Publicado: (2014)

Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
por: Lahousse, Lies, et al.
Publicado: (2017)

Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction
por: Kim, Victor, et al.
Publicado: (2015)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012)

Chronic Bronchitis
Publicado: (1901)

Chronic Bronchitis
Publicado: (1882)

For Chronic Bronchitis
Publicado: (1901)

Chronic Bronchitis
Publicado: (1890)

Chronic Bronchitis
Publicado: (1886)

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis
por: Ekberg-Aronsson, Marie, et al.
Publicado: (2005)

Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease
por: Kim, Victor, et al.
Publicado: (2021)

Efficacy and Safety of N-Acetylcysteine for Chronic Obstructive Pulmonary Disease and Chronic Bronchitis
por: Zhang, Li, et al.
Publicado: (2022)

The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review
por: Wu, Jian-Jun, et al.
Publicado: (2019)

Viral and atypical pathogens as causes of type 1 acute exacerbations of chronic bronchitis
por: Roessingh, Peter H., et al.
Publicado: (2008)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

Severe chronic non-bacterial osteomyelitis in combination with total MPO deficiency and responsiveness to TNFα inhibition
por: Sundqvist, Martina, et al.
Publicado: (2023)

Chronic bronchitis: High prevalence in never smokers and underdiagnosis— A population-based study in Colombia
por: Gonzalez-Garcia, Mauricio, et al.
Publicado: (2018)

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population
por: Pasquale, Margaret K, et al.
Publicado: (2012)

Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
por: Rovina, Nikoletta, et al.
Publicado: (2007)

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
por: Dreyse, Jorge, et al.
Publicado: (2015)

Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register
por: Larsson, Kjell, et al.
Publicado: (2021)

Benefits, for patients with late stage chronic obstructive pulmonary disease, of being cared for in specialized palliative care compared to hospital. A nationwide register study
por: Henoch, Ingela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17e59vuqv955fghj33fag8fskd